Beschreibung
Summary of current and emerging treatment modalities for non-scarring alopecia, organized by mechanism of action and targeted pathways.
FIGURE 2
DiagramSource Paper
Research progress in the treatment of non-scarring alopecia: mechanism and treatment.Cite This Figure
 > Source: Rui-Xian Guo et al. "Research progress in the treatment of non-scarring alopecia: mechanism and treat." *Frontiers in pharmacology*, 2025. PMID: [40487405](https://pubmed.ncbi.nlm.nih.gov/40487405/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12141338/bin/fphar-16-1544068-g002.jpg" alt="Summary of current and emerging treatment modalities for non-scarring alopecia, organized by mechanism of action and targeted pathways." /> <figcaption>FIGURE 2. Summary of current and emerging treatment modalities for non-scarring alopecia, organized by mechanism of action and targeted pathways.<br> Source: Rui-Xian Guo et al. "Research progress in the treatment of non-scarring alopecia: mechanism and treat." <em>Frontiers in pharmacology</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40487405/">40487405</a></figcaption> </figure>
Verwandte Evidenz
A
Minoxidil für Androgenetische Alopezie
A
Bewertung A · 299 Studien
Minoxidil für Alopecia Areata
A
Bewertung A · 122 Studien
Minoxidil für Telogen Effluvium
A
Bewertung A · 66 Studien
Finasterid für Androgenetische Alopezie
B
Bewertung A · 206 Studien
Eisen für Telogen Effluvium
Bewertung B · 62 Studien